STVN Stevanato Group S.p.A.
$19.43▼ -1.07%
Healthcare
Other
After hours
$19.43▲ +0.00%
Oct 28, 5:05 PM ET
Volume 277.6K
Avg Volume (10D) 409.6K
Key Metrics & Fundamentals
Market Cap
$5.31B
P/E Ratio
34.1
Div Yield
0.31%
52W Range
12.89 - 27.00
% vs 50 MA
-5.98%
% vs 200 MA
7.31%
RSI-14
43.9
MACD Histogram
+0.1000
Beta (1Y vs SPY)
1.08
Free Cash Flow
-$33.87M
Gross Rev
$302.00M
Gross Profit
$86.81M
EBITDA
$51.56M
COGS
$215.19M
Operating Exp
$35.53M
Operating Income
$51.28M
EBIT
$51.28M
Pretax Income
$38.12M
Net Income
$22.96M
EPS (Diluted)
0.08
Price & Volume History
Loading chart…
Recent News
Stevanato Group S.p.A. (STVN) Rallies on 2Q26 Revenue Growth and EBITDA Margin Expansion
Insider Monkey · Oct 28, 2026 12:15 PM ET
Stevanato Group and Aptar Pharma Collaborate to Help Accelerate Pre-Filled Syringe System Selection
Business Wire · Oct 27, 2026 7:00 AM ET
Aptar Pharma and Stevanato Group Collaborate to Help Accelerate Pre-Filled Syringe System Selection
Business Wire · Oct 27, 2026 7:00 AM ET
Stevanato Group to Report Third Quarter 2026 Financial Results on November 3, 2026
Business Wire · Oct 20, 2026 4:30 PM ET
Deutsche Bank Initiates Stevanato Group at Hold, $22 Price Target
MT Newswires · Oct 7, 2026 7:13 AM ET
Ensera launches alliance network with SHL Medical, Stevanato Group, Ypsomed, Argonaut and American Injectables
PR Newswire · Oct 1, 2026 9:00 AM ET
United Therapeutics (UTHR) Moves 12.6% Higher: Will This Strength Last?
Zacks · Oct 1, 2026 6:02 AM ET
electroCore (ECOR) Stock Jumps 6.9%: Will It Continue to Soar?
Zacks · Sep 18, 2026 9:09 AM ET
UBS Adjusts Price Target on Stevanato Group to $23 From $28, Keeps Neutral Rating
MT Newswires · Sep 9, 2026 9:35 AM ET
Stevanato Group to Participate in Two Upcoming Investor Conferences
Business Wire · Sep 8, 2026 4:05 PM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See STVN's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.